Archives
-
BIBR 1532: Practical Telomerase Assay Guidance
2026-09-28
A scenario-based guide to using BIBR 1532 (SKU A1945) in telomerase, proliferation, and apoptosis experiments. It distinguishes biochemical potency from cellular outcomes and provides practical preparation, control, interpretation, and product-selection considerations.
-
Tobramycin Workflows for MIC and Resistance Research
2026-09-27
Build reproducible Tobramycin broth microdilution assays around its 30S-ribosome activity, water compatibility, and fresh-solution handling. A classic aminoglycoside comparison provides useful assay-design lessons—but its sisomicin results should not be mistaken for Tobramycin MIC data.
-
Co-differentiating Vascularized Pancreatic Progenitors
2026-09-26
Sang and colleagues report a human pluripotent stem cell strategy that produces endodermal pancreatic progenitors alongside mesoderm-derived endothelial cells. The work combines low-dose CHIR99021 with mTeSR1, then uses VEGFA to increase endothelial differentiation, offering a route to study vascular support and pancreatic lineage development in a shared culture.
-
Sepsis, K+ Channels, and Renal Blood Flow
2026-09-25
This rat study paired isolated-kidney perfusion experiments with in vivo renal blood-flow measurements to examine how potassium-channel blockade affects responses to norepinephrine and phenylephrine during sepsis. Its findings show that blocking channels did not uniformly restore renal vascular responses and, in some septic animals, was associated with a greater fall in renal blood flow after vasoconstrictor administration.
-
BKT140 (BL-8040) for CXCR4 Assays
2026-09-25
Learn how to design and interpret CXCR4-focused chemotaxis, viability, and apoptosis experiments using BKT140 (BL-8040), SKU B7833. This scenario-driven guide covers controls, formulation, assay limitations, and practical criteria for selecting a research compound.
-
DOPE in mRNA Delivery: Workflow and Optimization
2026-09-24
Learn how to evaluate DOPE as a helper lipid in nucleic acid delivery, from stock preparation and formulation screens to cell-based performance checks. The workflow distinguishes DOPE’s membrane-fusion role from the pH-switching zwitterionic lipid studied in recent mRNA cancer-vaccine research.
-
Polybrene (Hexadimethrine Bromide) 10 mg/mL
2026-09-24
A practical guide to using Polybrene (Hexadimethrine Bromide) 10 mg/mL (SKU K2701) in viral delivery and cell-based viability workflows. Learn how to optimize exposure, distinguish delivery effects from toxicity, and assess product fit without assuming an unreported dose or performance gain.
-
Pol II Degradation Triggers Cell Death Beyond Transcription
2026-09-23
The study separates the consequences of removing RNA polymerase II (Pol II) from the effects of reduced transcription, reporting that Pol II degradation can activate cell death independently of transcription loss. This distinction offers a useful framework for interpreting transcription-targeting experiments, while emphasizing the need to measure polymerase abundance, transcriptional output, and cell death as separate outcomes.
-
Mithramycin A for Transcription Assays
2026-09-23
Mithramycin A is an anticancer antibiotic for controlled disruption of G-C-rich transcription, with practical value in c-myc, differentiation, and mechanism-focused assays. This workflow also shows how to test GC-dependent transcriptional contributions within doxorubicin-related cardiac injury models without treating an exploratory tool compound as a therapeutic solution.
-
10058-F4: A Mechanistic Assay Guide
2026-09-22
Explore 10058-F4, a c-Myc-Max dimerization inhibitor, through a mechanism-first framework linking transcriptional disruption to apoptosis and differentiation. This guide also explains how recent APEX2–TERT findings should—and should not—influence experimental design.
-
Saracatinib (AZD0530): An SFK Signaling Probe
2026-09-22
Saracatinib (AZD0530) is a dual Src/Abl kinase inhibitor that enables pathway-resolved studies of cancer cell proliferation, migration, and invasion. This article connects its oncology assay applications with the Reelin–Apoer2–SFK findings reported in PNAS, while distinguishing established evidence from cross-domain research hypotheses.
-
circ_0042103/TAF15/NER Axis in Pulpitis
2026-09-21
The reference study identifies circ_0042103 as a regulator connecting TAF15, nucleotide excision repair, DNA damage, and inflammation in dental pulp stem cells. Its integrated sequencing, molecular, and perturbation experiments support a mechanistic model in which circ_0042103 suppresses NER-associated proteins and intensifies LPS-related cellular injury, while also highlighting important limits for translation beyond the experimental pulpitis model.
-
IGFBP2–THBS1 Axis in GH-Mediated Bone Growth
2026-09-21
This study identifies an IGFBP2–THBS1 regulatory axis that helps explain how growth hormone promotes chondrocyte proliferation and hypertrophic differentiation in children with idiopathic short stature. By combining patient plasma proteomic analysis with human chondrocyte gain- and loss-of-function experiments, the authors connect GH exposure to enhanced IGF-1 signaling while defining important limits for clinical translation.
-
Lyso-Tracker Red Live-Cell Workflow
2026-09-20
Build a reproducible live-cell lysosome assay around Lyso-Tracker Red, from nanomolar staining and imaging to flow cytometry and trafficking analysis. The workflow translates lysosomal readouts into practical assay choices for nanoparticle research, including the intramacrophage bacterial-clearing strategy described in the reference study.
-
Mycophenolic acid in Whole-Blood Immunometabolism
2026-09-19
Use Mycophenolic acid as a pathway-focused dehydrogenase inhibitor to connect nucleotide metabolism with cytokine behavior in fresh human whole blood. This practical workflow emphasizes solvent control, donor-aware experimental design, and troubleshooting that distinguishes metabolic modulation from nonspecific toxicity.